Search

Your search keyword '"Kovacs JA"' showing total 341 results

Search Constraints

Start Over You searched for: Author "Kovacs JA" Remove constraint Author: "Kovacs JA" Database MEDLINE Remove constraint Database: MEDLINE
341 results on '"Kovacs JA"'

Search Results

1. CD40 Expression by B Cells Is Required for Optimal Immunity to Murine Pneumocystis Infection.

2. Alterations in the plasma proteome persist ten months after recovery from mild to moderate SARS-CoV-2 infection.

3. CD4, but not Cxcr6, is necessary for control of Pneumocystis murina infection.

4. Longitudinal analysis of the lung proteome reveals persistent repair months after mild to moderate COVID-19.

5. Exploring the influence of H-bonding and ligand constraints on thiolate ligated non-heme iron mediated dioxygen activation.

6. Retracing the evolution of Pneumocystis species, with a focus on the human pathogen Pneumocystis jirovecii .

7. Transcriptionally Active Defective HIV-1 Proviruses and Their Association With Immunological Nonresponse to Antiretroviral Therapy.

8. Development of Highly Efficient Universal Pneumocystis Primers and Their Application in Investigating the Prevalence and Genetic Diversity of Pneumocystis in Wild Hares and Rabbits.

9. Regional centromere configuration in the fungal pathogens of the Pneumocystis genus.

10. A Novel CARMIL2 Immunodeficiency Identified in a Subset of Cavalier King Charles Spaniels with Pneumocystis and Bordetella Pneumonia.

11. CD40 Expression by B cells is Required for Optimal Immunity to Murine Pneumocystis Infection.

12. Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/Rifapentine.

13. Long-term Outcomes of Patients With HIV and Pneumocystis jirovecii Pneumonia in the Antiretroviral Therapy Era.

14. Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections.

15. The Host Adapted Fungal Pathogens of Pneumocystis Genus Utilize Genic Regional Centromeres.

16. Persistence of Human Immunodeficiency Virus-Associated Cerebral Toxoplasmosis Lesions in Successfully Treated Patients Receiving Combination Antiretroviral Therapy.

17. Detection of Pneumocystis and Morphological Description of Fungal Distribution and Severity of Infection in Thirty-Six Mammal Species.

19. Mucosal-Associated Invariant T Cells Accumulate in the Lungs during Murine Pneumocystis Infection but Are Not Required for Clearance.

20. Electronic Structure and Reactivity of Dioxygen-Derived Aliphatic Thiolate-Ligated Fe-Peroxo and Fe(IV) Oxo Compounds.

21. Genetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States.

22. Increasing reactivity by incorporating π-acceptor ligands into coordinatively unsaturated thiolate-ligated iron(II) complexes.

23. A Novel Encochleated Formulation Improves Atovaquone Activity in a Murine Model of Pneumocystis Pneumonia.

24. Superoxide Oxidation by a Thiolate-Ligated Iron Complex and Anion Inhibition.

25. Influence of Thiolate versus Alkoxide Ligands on the Stability of Crystallographically Characterized Mn(III)-Alkylperoxo Complexes.

26. Genomic insights into the host specific adaptation of the Pneumocystis genus.

27. Comparison of two Mn IV Mn IV -bis-μ-oxo complexes {[Mn IV (N 4 (6-Me-DPEN))] 2 (μ-O) 2 } 2+ and {[Mn IV (N 4 (6-Me-DPPN))] 2 (μ-O) 2 } 2 .

28. MUC1 mediates Pneumocystis murina binding to airway epithelial cells.

29. Humans Are Selectively Exposed to Pneumocystis jirovecii.

30. Diversity and Complexity of the Large Surface Protein Family in the Compacted Genomes of Multiple Pneumocystis Species.

31. Advances toward Curing HIV-1 Infection in Tissue Reservoirs.

32. How Metal Ion Lewis Acidity and Steric Properties Influence the Barrier to Dioxygen Binding, Peroxo O-O Bond Cleavage, and Reactivity.

33. Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controller.

34. Geometric and electronic structure of a crystallographically characterized thiolate-ligated binuclear peroxo-bridged cobalt(III) complex.

35. Characterization of Pneumocystis murina Bgl2, an Endo-β-1,3-Glucanase and Glucanosyltransferase.

36. Formation of a Reactive, Alkyl Thiolate-Ligated Fe III -Superoxo Intermediate Derived from Dioxygen.

37. Genetic diversity of Pneumocystis jirovecii from a cluster of cases of pneumonia in renal transplant patients: Cross-sectional study.

38. The Major Surface Glycoprotein of Pneumocystis murina Does Not Activate Dendritic Cells.

39. Accurate flexible refinement of atomic models against medium-resolution cryo-EM maps using damped dynamics.

40. Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine.

41. Characterization of p57, a Stage-Specific Antigen of Pneumocystis murina.

42. A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

44. Comparative Population Genomics Analysis of the Mammalian Fungal Pathogen Pneumocystis .

45. Tracing Actin Filament Bundles in Three-Dimensional Electron Tomography Density Maps of Hair Cell Stereocilia.

46. How Do Ring Size and π-Donating Thiolate Ligands Affect Redox-Active, α-Imino-N-heterocycle Ligand Activation?

47. Iron L 2,3 -Edge X-ray Absorption and X-ray Magnetic Circular Dichroism Studies of Molecular Iron Complexes with Relevance to the FeMoco and FeVco Active Sites of Nitrogenase.

48. Pulmonary Interleukin-17-Positive Lymphocytes Increase during Pneumocystis murina Infection but Are Not Required for Clearance of Pneumocystis.

49. Computing Spatiotemporal Heat Maps of Lipid Electropore Formation: A Statistical Approach.

50. A Balanced Approach to Adaptive Probability Density Estimation.

Catalog

Books, media, physical & digital resources